ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Developing Hypoimmunogenic Human iPSC-Derived Oligodendrocyte Progenitor Cells as an Off-The-Shelf Cell Therapy for Myelin Disorders.

Lizhao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.